Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
81.00    -2.50 (-2.99%)
Bid:
80.00
Ask:
82.00
Spread: 2.00 (2.50%)
Market Cap: £11.75m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Contract Gain

11 Apr 2006 07:30

Adventis Group PLC11 April 2006 For release Adventis Group plc ("Adventis") Contract Gain Adventis ("ATG/L"), the multimedia marketing and advertising agency, announcesthat Affiniti UK Ltd, its Bucks-based healthcare agency has been appointed bySanofi Pasteur MSD, an existing client, to work on a campaign for a new vaccinethat could protect the elderly against shingles. An attack of shingles can be extremely painful, with around a quarter ofsufferers going on to develop post herpetic neuralgia, an often debilitatingillness which can last for months or even years. In the UK, about 250,000 peoplesuffer from shingles each year, almost half of these being over 60 years old. Affiniti won this 3-way pitch with a strong strategic approach, which furtherextends their vaccine product portfolio. Commenting, Affiniti MD, Stuart Tennant, said: "Everyone in the agency isdelighted. We continue to build market share in the healthcare sector," whereas,Charles Phillpot, Adventis CEO said in his statement for the year ended 31December 2005: "Revenue by sector grew over that achieved in the previous year." - ENDS - Editor's NotesAdventis Group plc is an AIM listed, full service marketing and advertisingagency, providing services to the property, healthcare and financial servicesindustries.Through its six operating companies the company provides a complete range ofcommunication services, including corporate identity programmes, advertisingcampaigns, media planning & buying, literature, public relation, packaging,exhibitions, research and planning, interiors, signage and digital media.Adventis employs over 80 staff in London and the South East.www.adventis.co.uk In January 2005, Adventis acquired Affiniti (UK) Ltd, a specialised UKhealthcare advertising agency with clients such as Allergan, Sanofi Pasteur MSD,Chiron Vaccines, Eden Biopharm, Leo Pharma and Serono. The acquisition hasperformed very well in 2005 with a pre-tax profit of £247,000 and builds on thefoothold Adventis Group already had in this profitable market. Enquiries: Adventis Group plcCharles Phillpot, Chief Executive Officer 020 7034 4750 Affiniti (UK) LtdStuart Tennant, Managing Director 01494 775 213 Seymour PierceJohn Depasquale 020 7107 8000 Binns & Co PR Ltd 020 7786 9600Peter Binns 07768 392 582Annie Evangeli 07778 507 162 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Dec 20233:42 pmRNSHolding(s) in Company
5th Dec 20237:00 amRNS£5.2 million received for the sale of Corallian
1st Dec 20237:00 amRNSItalian Government Decree on Energy Sector
22nd Nov 20235:10 pmRNSRequisition of General Meeting
17th Nov 20237:00 amRNSFurther Investment into LNEnergy
14th Nov 20237:00 amRNSPurported Requisition of General Meeting
8th Nov 202310:50 amRNSRequisition of General Meeting
3rd Nov 20234:10 pmRNSResponse to Media Reporting
3rd Nov 20234:02 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSUnaudited Interim Results
27th Sep 20237:00 amRNSApproval for EA Permit at West Newton
12th Sep 20237:00 amRNSFurther Investment into LNEnergy
5th Sep 20237:00 amRNSColle Santo Project Enters Operational Phase
7th Aug 20237:00 amRNSUpdate on LNEnergy and the Colle Santo gas field
24th Jul 202312:24 pmRNSHolding(s) in Company
21st Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20237:00 amRNSTransaction in Own Shares
18th Jul 20237:00 amRNSTransaction in Own Shares
14th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:00 amRNSHigh-grading of North Sea Licences
10th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:20 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSNew Corporate Presentation
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSTransaction in Own Shares
29th Jun 20231:01 pmRNSStandard form for notification of major holdings
29th Jun 202312:56 pmRNSContinuation of Share Buyback Programme
29th Jun 202312:45 pmRNSResult of AGM
29th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:36 amRNSTransaction in Own Shares
23rd Jun 20237:01 amRNSCompletion of Further Investment in LNEnergy
22nd Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 20237:00 amRNSTransaction in Own Shares
14th Jun 20237:00 amRNSTransaction in Own Shares
13th Jun 20237:00 amRNSTransaction in Own Shares
12th Jun 20231:35 pmRNSChange of Admission Date
12th Jun 20237:01 amRNSFurther Investment in LNEnergy
12th Jun 20237:00 amRNSTransaction in Own Shares
9th Jun 20237:00 amRNSTransaction in Own Shares
8th Jun 20237:45 amRNSInvestment in LNEnergy Update
7th Jun 20237:00 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
2nd Jun 20233:55 pmRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.